Indication includes all adults 65 and older, and those ages 12 to 64 with a high-risk conditionThe FDA has issued a long-awaited approval of Novavax’s COVID-19 vaccine (Nuvaxovid), but with unusual restrictions.Novavax makes the nation’s only traditional protein-based coronavirus vaccine — and until now it had emergency authorization from FDA for use in anyone 12 […]
